A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa

被引：62
作者：
Gottlieb, Geoffrey S. [1 ]
Eholie, Serge-Paul [2 ]
Nkengasong, John N. [3 ]
Jallow, Sabelle [4 ,6 ]
Rowland-Jones, Sarah [4 ]
Whittle, Hilton C. [4 ]
Sow, Papa Salif [5 ]
机构：
[1] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA
[2] CHU Treichville, Serv Malad Infect & Trop, Abidjan, Cote Ivoire
[3] Ctr Dis Control & Prevent, Atlanta, GA USA
[4] MRC Labs, Fajara, Gambia
[5] Univ Cheikh Anta Diop Dakar, CHU Fann, Clin Malad Infect Ibrahima Diop Mar, Dakar, Senegal
[6] Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium
来源：
AIDS | 2008年 / 22卷 / 16期
基金：
英国医学研究理事会;
关键词：
Africa; antiretroviral; controlled trial; HIV-2; resource limited;
D O I：
10.1097/QAD.0b013e32830edd44
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2069 / 2072
页数：4
相关论文
共 65 条
  • [1] Antiretroviral therapy in HIV-2-infected patients:: changes in plasma viral load, CD4+cell counts, and drug resistance profiles of patients treated in Abidjan, Cote d'Ivoire
    Adjé-Touré, CA
    Cheingsong, R
    Garcìa-Lerma, JG
    Eholié, S
    Borget, MY
    Bouchez, JM
    Otten, RA
    Maurice, C
    Sassan-Morokro, M
    Ekpini, RE
    Nolan, M
    Chorba, T
    Heneine, W
    Nkengasong, JN
    [J]. AIDS, 2003, 17 : S49 - S54
  • [2] Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients
    Alabi, AS
    Jaffar, S
    Ariyoshi, K
    Blanchard, T
    van der Loeff, MS
    Awasana, AA
    Corrah, T
    Sabally, S
    Sarge-Njie, R
    Cham-Jallow, F
    Jaye, A
    Berry, N
    Whittle, H
    [J]. AIDS, 2003, 17 (10) : 1513 - 1520
  • [3] Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa -: Significantly, lower plasma virus set point in HIV-2 infection than in HIV-1 infection
    Andersson, S
    Norrgren, H
    da Silva, Z
    Biague, A
    Bamba, S
    Kwok, S
    Christopherson, C
    Biberfeld, G
    Albert, J
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (21) : 3286 - 3293
  • [4] ANDREASSON PA, 1993, AIDS, V7, P989, DOI 10.1097/00002030-199307000-00013
  • [5] Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa
    Ariyoshi, K
    Jaffar, S
    Alabi, AS
    Berry, N
    van der Loeff, MS
    Sabally, S
    N'Gom, PT
    Corrah, T
    Tedder, R
    Whittle, H
    [J]. AIDS, 2000, 14 (04) : 339 - 344
  • [6] Why do HIV-1 and HIV-2 use different pathways to develop AZT resistance?
    Boyer, Paul L.
    Sarafianos, Stefan G.
    Clark, Patrick K.
    Arnold, Eddy
    Hughes, Stephen H.
    [J]. PLOS PATHOGENS, 2006, 2 (02) : 101 - 111
  • [7] pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy
    Brandin, E
    Lindborg, L
    Gyllensten, K
    Broström, C
    Hagberg, L
    Gisslen, M
    Tuvesson, B
    Blaxhult, A
    Albert, J
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 (07) : 543 - 550
  • [8] Inhibition of HIV-2 protease by HIV-1 protease inhibitors in clinical use
    Brower, Evan T.
    Bacha, Usman M.
    Kawasaki, Yuko
    Freire, Ernesto
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 71 (04) : 298 - 305
  • [9] Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel
    Carpenter, CCJ
    Fischl, MA
    Hammer, SM
    Hirsch, MS
    Jacobsen, DM
    Katzenstein, DA
    Montaner, JSG
    Richman, DD
    Saag, MS
    Schooley, RT
    Thompson, MA
    Vella, S
    Yeni, PG
    Volberding, PA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24): : 1962 - 1969
  • [10] Clark NM, 1998, AIDS, V12, P2506
1234567